Breast Inflammatory Carcinoma — Trials

Breast Inflammatory Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03101748	Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer	terminated	Phase 1 / Phase 2	34	M.D. Anderson Cancer CenterOTHER	1	Feb 12, 2026	clinicaltrials
NCT05041101	Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer	terminated	Phase 1 / Phase 2	6	M.D. Anderson Cancer CenterOTHER	1	Jun 13, 2025